STOCK TITAN

All-cash $10.90 deal would take Kennedy-Wilson (KW) private with Fairfax backing

(Moderate)
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Fairfax-led investors filed an amended Schedule 13D detailing a take-private agreement for Kennedy-Wilson Holdings. The company agreed to merge with a Fairfax-backed entity, with each common share converted into the right to receive $10.90 in cash at closing.

At the same time, Fairfax committed $1,650,000,000 of equity financing to fund the merger consideration, related payments and preferred stock redemptions, or certain damages if the buyers breach. The filing also restates that Fairfax-affiliated entities beneficially own 30,951,179 common shares, or 19.9% of the class, limited by warrant exercise caps.

Positive

  • All-cash merger consideration of $10.90 per share for Kennedy-Wilson common stock, backed by a $1,650,000,000 Fairfax equity commitment, creates a defined liquidity event for shareholders if the transaction satisfies its closing conditions.

Negative

  • None.

Insights

Fairfax backs an all-cash $10.90 take-private of Kennedy-Wilson with a $1.65B equity commitment.

Kennedy-Wilson agreed to merge with a Fairfax-sponsored vehicle, where common shareholders receive $10.90 per share in cash. The filing explains that Merger Sub will combine into the company, which will then be privately owned by the buyer group and rollover holders.

The deal includes a substantial $1,650,000,000 equity commitment from Fairfax to fund the merger consideration, related payments and Series A preferred redemption, or up to $400,000,000 of damages if the buyer fails to close under specified conditions. Closing still depends on multiple stockholder approvals, regulatory clearances, and the absence of a defined Material Adverse Effect.

Fairfax-related entities report beneficial ownership of 30,951,179 shares, or 19.9% of the class, constrained by warrant exercise limits, with potential as-converted ownership of 38,703,549 shares at 23.7%. Future company and proxy filings are expected to provide more detail on timing and the shareholder vote process.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What merger has Kennedy-Wilson (KW) agreed to enter into?

Kennedy-Wilson agreed to merge with Kona Merger Subsidiary, a unit of Kona Bidco backed by Fairfax. At closing, Merger Sub combines into Kennedy-Wilson, which then becomes a privately held surviving corporation owned by the buyer group and specified rollover stockholders.

What will Kennedy-Wilson (KW) common shareholders receive in the merger?

Each outstanding Kennedy-Wilson common share is to be converted into the right to receive $10.90 in cash, without interest. Certain excluded shares, rollover shares and properly perfected appraisal shares are carved out and do not receive this standard cash merger consideration under the agreement’s terms.

How much equity financing is Fairfax providing for the Kennedy-Wilson (KW) deal?

Fairfax provided an equity commitment letter for $1,650,000,000. This commitment is intended to fund the aggregate cash merger consideration, other required payments including Series A preferred redemptions, or up to $400,000,000 of monetary damages if the buyer must pay under a qualifying breach scenario.

What approvals are required for the Kennedy-Wilson (KW) merger to close?

The merger requires company stockholder approvals, including a majority of outstanding voting power across common and preferred securities voting as one class, and a separate majority of votes cast excluding specified voting and support parties, plus regulatory clearances, no prohibitive laws, and satisfaction of customary accuracy and covenant conditions.

How many Kennedy-Wilson (KW) shares are used to calculate Fairfax’s ownership?

Ownership percentages are based on 155,533,564 shares deemed outstanding under Rule 13d-3. This includes 137,904,394 shares reported outstanding as of November 4, 2025, plus 17,629,170 shares underlying warrants held by the reporting persons, excluding 7,752,370 warrant shares that cannot currently be exercised.





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
Shares beneficially owned by the Reporting Persons are held or issuable to pursuant to warrants. Certain of the warrants are subject to a limitation on a holder's right to exercise such warrants and receive Shares that results in beneficial ownership in excess of 19.9% of the then-outstanding Shares or the voting power thereof, unless and until the requisite shareholder approval is obtained. As a result of such restriction, the Reporting Persons are deemed to beneficially own only 30,951,179 Shares. Without giving effect to such restriction, the Reporting Persons would be deemed to beneficially own 38,703,549 Shares, representing approximately 23.7% of the outstanding Shares on an as-converted basis.


SCHEDULE 13D




Comment for Type of Reporting Person:
Shares beneficially owned by the Reporting Persons are held or issuable to pursuant to warrants. Certain of the warrants are subject to a limitation on a holder's right to exercise such warrants and receive Shares that results in beneficial ownership in excess of 19.9% of the then-outstanding Shares or the voting power thereof, unless and until the requisite shareholder approval is obtained. As a result of such restriction, the Reporting Persons are deemed to beneficially own only 30,951,179 Shares. Without giving effect to such restriction, the Reporting Persons would be deemed to beneficially own 38,703,549 Shares, representing approximately 23.7% of the outstanding Shares on an as-converted basis.


SCHEDULE 13D




Comment for Type of Reporting Person:
Shares beneficially owned by the Reporting Persons are held or issuable to pursuant to warrants. Certain of the warrants are subject to a limitation on a holder's right to exercise such warrants and receive Shares that results in beneficial ownership in excess of 19.9% of the then-outstanding Shares or the voting power thereof, unless and until the requisite shareholder approval is obtained. As a result of such restriction, the Reporting Persons are deemed to beneficially own only 30,951,179 Shares. Without giving effect to such restriction, the Reporting Persons would be deemed to beneficially own 38,703,549 Shares, representing approximately 23.7% of the outstanding Shares on an as-converted basis.


SCHEDULE 13D




Comment for Type of Reporting Person:
Shares beneficially owned by the Reporting Persons are held or issuable to pursuant to warrants. Certain of the warrants are subject to a limitation on a holder's right to exercise such warrants and receive Shares that results in beneficial ownership in excess of 19.9% of the then-outstanding Shares or the voting power thereof, unless and until the requisite shareholder approval is obtained. As a result of such restriction, the Reporting Persons are deemed to beneficially own only 30,951,179 Shares. Without giving effect to such restriction, the Reporting Persons would be deemed to beneficially own 38,703,549 Shares, representing approximately 23.7% of the outstanding Shares on an as-converted basis.


SCHEDULE 13D




Comment for Type of Reporting Person:
Shares beneficially owned by the Reporting Persons are held or issuable to pursuant to warrants. Certain of the warrants are subject to a limitation on a holder's right to exercise such warrants and receive Shares that results in beneficial ownership in excess of 19.9% of the then-outstanding Shares or the voting power thereof, unless and until the requisite shareholder approval is obtained. As a result of such restriction, the Reporting Persons are deemed to beneficially own only 30,951,179 Shares. Without giving effect to such restriction, the Reporting Persons would be deemed to beneficially own 38,703,549 Shares, representing approximately 23.7% of the outstanding Shares on an as-converted basis.


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


V. PREM WATSA
Signature:/s/ V. Prem Watsa
Name/Title:V. Prem Watsa
Date:02/18/2026
THE SECOND 810 HOLDCO LTD
Signature:/s/ V. Prem Watsa
Name/Title:V. Prem Watsa, Director
Date:02/18/2026
THE SECOND 1109 HOLDCO LTD.
Signature:/s/ V. Prem Watsa
Name/Title:V. Prem Watsa, President
Date:02/18/2026
THE SIXTY TWO INVESTMENT COMPANY LIMITED
Signature:/s/ V. Prem Watsa
Name/Title:V. Prem Watsa, President
Date:02/18/2026
FAIRFAX FINANCIAL HOLDINGS LIMITED
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, President and Chief Operating Officer
Date:02/18/2026
FFHL GROUP LTD.
Signature:/s/ V. Prem Watsa
Name/Title:V. Prem Watsa, President
Date:02/18/2026
FAIRFAX (US) INC
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ODYSSEY GROUP HOLDINGS, INC.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ODYSSEY REINSURANCE CO
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
NEWLINE HOLDINGS UK LIMITED
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
NEWLINE CORPORATE NAME LIMITED
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
CRUM & FORSTER HOLDINGS CORP.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
UNITED STATES FIRE INSURANCE CO
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
THE NORTH RIVER INSURANCE COMPANY
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
TIG INSURANCE CO
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
RESOLUTION GROUP REINSURANCE (BARBADOS) LIMITED
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ZENITH NATIONAL INSURANCE CORP.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ZENITH INSURANCE COMPANY
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
NORTHBRIDGE FINANCIAL CORPORATION
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
FAIRFAX (BARBADOS) INTERNATIONAL CORP.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
WENTWORTH INSURANCE COMPANY LTD.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
FAIRFAX UK HOLDINGS LIMITED
Signature:/s/ Michael Wallace
Name/Title:Michael Wallace, Director
Date:02/18/2026
BRIT GROUP HOLDINGS LIMITED
Signature:/s/ Gavin Wilkinson
Name/Title:Gavin Wilkinson, Group Chief Financial Officer
Date:02/18/2026
BRIT INSURANCE HOLDINGS LIMITED
Signature:/s/ Gavin Wilkinson
Name/Title:Gavin Wilkinson, Group Chief Financial Officer
Date:02/18/2026
BRIT SYNDICATES LIMITED
Signature:/s/ Gavin Wilkinson
Name/Title:Gavin Wilkinson, Group Chief Financial Officer
Date:02/18/2026
BRIT REINSURANCE (BERMUDA) LIMITED
Signature:/s/ Gavin Wilkinson
Name/Title:Gavin Wilkinson, Group Chief Financial Officer
Date:02/18/2026
1102952 B.C. UNLIMITED LIABILITY COMPANY
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ALLIED WORLD ASSURANCE COMPANY HOLDINGS, LTD
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ALLIED WORLD ASSURANCE COMPANY HOLDINGS I, LTD
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ALLIED WORLD ASSURANCE COMPANY, LTD
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ALLIED WORLD ASSURANCE HOLDINGS (IRELAND) LTD
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ALLIED WORLD ASSURANCE HOLDINGS (U.S.) INC.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ALLIED WORLD INSURANCE COMPANY
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
AW UNDERWRITERS INC.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ALLIED WORLD SPECIALTY INSURANCE COMPANY
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ALLIED WORLD SURPLUS LINES INSURANCE COMPANY
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ALLIED WORLD ASSURANCE COMPANY (U.S.) INC.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
ALLIED WORLD ASSURANCE COMPANY (EUROPE) DAC
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
CRC REINSURANCE LIMITED
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:02/18/2026
Comments accompanying signature:
Attorney-in-Fact signing pursuant to powers of attorney referenced in Exhibits 99.28, 99.29 and 99.30.